Medical Product Outsourcing Magazine
September 2019
-
Assembling with Reliability and Repeatability Through Automation
Progress in assembly and automation technologies enable manufacturers to leverage capabilities such as Industry 4.0 and IoT for medical device fabrication.09.09.19
-
Shock to the System: An Examination of Neurostim Technologies
Targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.09.09.19
-
Customized Connections: A Discussion on Custom Electronics
Demand for more complex, traceable, integrated solutions are driving innovation in the fast-changing medical electronics market.09.09.19
-
Washington RoundupHealthcare, Breakthrough Technology, and the 2020 Election: A Summer UpdateWith only a year and two months until the 2020 presidential election, Washington is buckled down and ready for yet another busy season of campaigning.09.06.19
-
Design ViewpointThree Crucial Elements of Conducting International Usability ResearchIt is important to conduct usability research throughout the product development cycle.09.06.19
-
Dollars & SenseTrends, Opportunities, and Drivers in Early-Stage Life Sciences InvestingDespite trade wars and economic shifts in China and the EU, early-stage investing in life sciences remained strong in Q1 2019.09.06.19
-
The Supply ChainJ&J-Jabil Deal Truly Is Transformative for the Medtech Supply ChainOn Aug. 2, 2018 Johnson & Johnson announced a reorganization of its Medical Devices division.09.06.19
-
Regulatory PerspectivesFirst Come, First Served: Class I Manufacturers Stand in Line for EU MDR CertificationThe days remaining to attain EU Medical Device Regulation (MDR) compliance are numbered.09.06.19
-
DatawatchUpdate on Integrated Delivery Networks and Physician EmploymentThe top five IDNs employ 135,913 MDs and DOs in the U.S., approximately 15 percent of all active physicians in the country.09.06.19
-
Best PracticesU.S. May Offer a Safe Harbor from the Impending MDR StormU.S. may represent the preferred route to market with regulatory changes elsewhere in the world, like the EU's MDR.09.06.19
-
EditorialThe Legacy of Apple HealthDoes Apple Health present the opportunity to be the company's greatest contribution to mankind or will it falter due to a lack of direction?09.06.19
-
ColumnsThe TAVR Plot ThickensTranscatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.09.06.19
-
ColumnsInnovating for the Clinical Space: An Interview with Clinical Innovations' President/CEO Ken RealiKen Reali of Clinical Innovations speaks with Sean Fenske about current issues impacting medical device manufacturing and emerging trends influencing care.09.06.19
-
ColumnsGlobalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?Successful medtech leaders have ongoing regulatory strategies for their respective businesses.09.06.19
